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Background: Metabolic syndrome (MetS) is associated with carotid intima-media thickness (CIMT), which is a good
predictor of cardiovascular disease (CVD). However, among individuals with MetS, direct comparative data regarding
the utility of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio to diagnose carotid atherosclerosis are scarce,
particularly in Chinese populations. We aimed to determine the relationship between the apoB/apoAΙ ratio and the
non-HDL-C/HDL-C ratio and carotid atherosclerosis among Chinese individuals with MetS.
Methods: We performed a retrospective study of 5822 Chinese participants who underwent a routine health
screening examination. Lipid profiles, fasting glucose, fasting insulin, CRP, apoB, apoAΙ and CIMT were measured.
Results: We observed that among Chinese individuals with MetS, men (53.95 ± 0.58 ys) developed carotid
atherosclerosis at a younger age than women (58.47 ± 1.17 ys) (P < 0.001). Both the apoB/apoAΙ ratio and the
non-HDL-C/HDL-C ratio positively correlated with carotid atherosclerosis among Chinese individuals with MetS,
particularly among women. Meanwhile, CIMT increased progressively across the quartiles of the non-HDL-C/HDL-C
ratio (P for trend, < 0.05). Receiver Operating Characteristic (ROC) analysis indicated that the AUC of the apoB/apoAΙ
ratio (0.561) was higher than that of the non-HDL-C/HDL-C ratio (0.522) in men (P < 0.05) and the AUC of the apoB/
apoAΙ ratio (0.640) was lower than that of the non-HDL-C/HDL-C ratio (0.695) in women (P < 0.05). Among Chinese
individuals with MetS, the AUC of the non-HDL-C/HDL-C ratio was more prominent among women compared with
men (P < 0.05).
Conclusion: Our findings indicate that among individuals with MetS, Chinese men develop carotid atherosclerosis
at a much younger age than women. There were no significant differences between the apoB/apoAΙ ratio and the
non-HDL-C/HDL-C ratio for the prediction of carotid atherosclerosis among Chinese individuals with MetS. Among
Chinese individuals with MetS, the utility of the non-HDL-C/HDL-C ratio was found to be greater among women
than among men.
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Metabolic syndrome (MetS) is strongly associated with
various cardiovascular risk factors, including visceral
obesity, hypertension, hypertriglyceridemia, a low level
of high density lipoprotein cholesterol, and impaired
glucose tolerance [1,2]. Individuals with MetS are at an
increased risk of developing cardiovascular disease, car-
diovascular morbidity, mortality, and all-cause mortality
[3,4]. The prevalence is estimated to be approximately
34% among adults in the USA [5], and 14%-17% among
adults in China [6]. These rates are likely to increase due
to the aging of the population.
Carotid intima-media thickness (CIMT) is an early in-
dicator of atherosclerosis [7,8], and is a validated meas-
urement of subclinical atherosclerosis [9]. Among the
indicators of cardiovascular disease, CIMT is considered
to be an early marker of the disease; therefore, it is
widely used as a diagnostic tool [10,11]. Several studies
have used both the apolipoprotein B (apoB)/apolipopro-
tein AΙ (apoAΙ) ratio and the non-HDL-C/HDL-C ratio
to estimate the likelihood of having carotid atheroscler-
osis. In the setting of both type 2 diabetes mellitus and
normal glucose tolerance (NGT), the apoB/apoAΙ ratio
is more strongly associated with CIMT than conven-
tional lipids [12,13]. Generally, the non-HDL-C/HDL-C
ratio is believed to be superior to traditional lipid vari-
ables in estimating arterial stiffness among middle-aged
and elderly Chinese individuals [14].
Several studies have described the relationship be-
tween MetS and CIMT [3,15-17]. However, direct com-
parative data regarding the utility of the apoB/apoAΙ
ratio, the non-HDL-C/HDL-C ratio, insulin resistance
(IR), conventional lipids and the relationship between
these parameters and increased CIMT are scarce among
individuals with MetS. Given the increasing incidence of
MetS in China, it is important to identify the best
method with which to assess the risk of cardiovascular
disease (CVD). Very few studies have assessed the util-
ity of apolipoprotein and lipoprotein cholesterol mea-
surements in determining the risk of CVD among
Chinese individuals. In the present study, we examined
the relationship among carotid atherosclerosis, the apoB/
apoAΙ ratio, and the non-HDL-C/HDL-C ratio, as well
as conventional lipids, IR, and C reactive protein (CRP),
among Chinese individuals with MetS. We also aimed




We collected data from 5822 subjects between 18 and
85 years of age who underwent a health examination at the
Second Affiliated Hospital, School of Medicine, Zhejiang
University, between September 2011 and December 2012.Most of the patients were from Zhejiang province. 4908 in-
dividuals were included in the statistical analysis, of whom
3039 men, aged 45.12 ± 9.10 years, and 1869 women, aged
44.92 ± 9.79 years (P > 0.05) were ultimately included in the
study, following the exclusion of individuals with either car-
diovascular or cerebrovascular disease, cancer, diabetes, se-
vere mental disorders, or chronic kidney disease [19], as
well as individuals receiving lipid-lowering agents, anti-
thyroid agents, and individuals with acute and chronic
liver disease, infectious diseases, acute and chronic fe-
vers of unknown origin, and who consumed excessive
alcohol [20]. Among these individuals, 1863 were diag-
nosed with MetS, 1492 of which were men, with a mean
age of 46.80 ± 8.83 years, and 371 were women, with a
mean age of 51.09 ± 9.39 years (P < 0.001). This study
was reviewed and approved by the institutional review
board of the Second Affiliated Hospital of Zhejiang
University School of Medicine (ethical review code:
Research 2014–113). All subjects provided written in-
formed consent.
The definition of metabolic syndrome
In our study, metabolic syndrome was defined by the pres-
ence of 3 or more of the following conditions, based on
the NECP ATP III criteria [21]: 1) waist circumference
(WC) ≥ 90 cm in men and ≥ 80 cm in women, 2) triglycer-
ides ≥ 150 mg/dL, 3) HDL cholesterol < 40 mg/dL in men
and < 50 mg/dL in women, 4) blood pressure ≥ 130/
85 mm Hg or receiving antihypertensive medication, and
5) fasting glucose ≥ 100 mg/dL.
Questionnaire and physical examination
A standardised questionnaire was generated by a phys-
ician to collect baseline information such as age, gender,
smoking habits and drinking habits. A physical examin-
ation was performed by a physician to collect informa-
tion such as weight, height and waist circumstance. The
body mass index was calculated as the weight in kilo-
grams divided by the height in meters squared. Both sys-
tolic and diastolic blood pressure were measured in the
right following 5 minutes of rest, with the patient in a
sitting position, using an automated device (Omron 711,
USA), and the mean of two consecutive blood pressure
measurements was recorded.
Laboratory tests
All subjects fasted for 12 hours, and their venous blood
samples were collected for the measurement of fasting
plasma glucose (FPG), blood profiles (total cholesterol:
TC, triglyceride: TG, high density lipoprotein–cholesterol:
HDL-C, low density lipoprotein- cholesterol: LDL-C, apo-
lipoprotein B: apoB, apolipoprotein AΙ: apoAΙ), homocyst-
eine (HCY), gamma-glutamyl transpeptidase (GGT), uric
acid (UA), fasting insulin (FINS), and C-reactive protein
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method; TC was measured via the cholesterol oxidase-
peroxidase method (CHO-POD); TG was measured via
the glycerol phosphate oxidase-peroxidase method; HDL-
C was measured via the direct method-surfactant clear-
ance method; LDL-C was measured via the direct
method-selected inhibitor method; HCY was measured
using an enzymatic cycling assay; GGT was measured via
the modified SZASZ method; UA was measured via the
urease-peroxidase method; ApoB, apoAΙ, and CRP were
each measured using a turbidimetric immunoassay with a
BECKMAN COULTER AU5400 Analyzer. FINS was mea-
sured via direct chemical luminescence using with a SIE-
MENS ADVIA CENTAUR XP Analyzer. The homeostasis
model assessment of insulin resistance (HOMA-IR) was
calculated based on the HOMA model, as follows:
HOMA-IR = fasting glucose (mmol/L) * fasting plasma in-
sulin (mU/L)/22.5.
To guarantee both the accuracy and the comparability
of the results, two quality control materials (products of
BIO-RAD, lot numbers of liquid assayed multiqual:
45641 and 45643, lipids control: 57251 and 57252) of
different concentrations were tested each day. The cu-
mulative CVs were as follows: FPG (1.83%; 1.73%), TG
(4.0%; 2.56%), TC (2.05%; 1.92%), HDL-C (2.60%; 2.70%),
LDL-C (3.03%; 3.01%), apoB (<10%; <10%), apoAΙ
(<10%; <10%), GGT (<6%; <4%), HCY (<6%; <6%), UA
(<3%; <3%), FINS (<10%; <10%), and CRP (<10%; <10%).
Carotid ultrasound measurement
CIMT measurements were performed by an experienced
sonographer, using a high-resolution B-mode tomo-
graphic ultra-sound system (GE LOGIQ E9, USA), with
a linear 9 MHz transducer. The distal segment and
stigma compartments of the cephalic artery and the
proximal segment of the internal carotid artery were
measured on both sides [22]. The transducer was manip-
ulated so that the luminal diameter was maximised in
the longitudinal plane. Each of the above blood vessels
was measured in three different sections, within a range
of 1 cm in the proximal wall and distant from the side-
walls. Carotid atherosclerosis was diagnosed when CIMT
was ≥ 0.9 mm [23,24].
Statistical analysis
All statistical analyses were performed using SPSS 17 soft-
ware. Data were expressed either as means ± S.D. or as
geometrical means (95% confidence intervals [CIs]) for the
continuous variables, and as percentages for the categor-
ical variables. TG was analysed after log-transformation
due to a skewed distribution. General characteristics were
compared separately among participants with and without
carotid atherosclerosis, in both men and women with
MetS, using the Student’s t-test. The categorical variableswere analysed via the Chi-square test. Spearman correl-
ation coefficients were used to study the relationships be-
tween the different risk factors and carotid atherosclerosis.
The relationships between the different lipid ratios and ca-
rotid atherosclerosis were each assessed using binary logis-
tic regression analysis with forward selection method and
multinomial logistic regression analysis. Odds ratios (ORs)
and 95% confidence intervals (CIs) for carotid atheroscler-
osis were each calculated. Regarding the multinomial lo-
gistic regression analysis, age, body mass index (BMI),
systolic blood pressure (SBP), diastolic blood pressure
(DBP), TC, TG, HDL-C, LDL-C, apoB, apoAΙ, INS, IR,
CRP, HCY, GGT, and UA were included as covariates. To
assess the utility of the different lipid ratios as markers of
MetS, we constructed sex-specific Receiver Operating
Characteristic (ROC) curves and compared the areas
under the ROC curves (AUCs) with the Z-statistic. A P
value less than 0.05 was considered to be statistically
significant.
Results
The relationship between MetS and carotid
atherosclerosis
A total of 4908 subjects were included in the analysis.
The sample consisted of 3039 men and 1869 women.
The age range was 20–84 years in men and 20–83 years
in women. Based on the NECP ATP III criteria, 1863
people were diagnosed with MetS, which was present in
49.1% (1492/3039) of men and 19.9% (371/1869) of
women. Among Chinese individuals with MetS, 16.6%
(309/1863) of the individuals had carotid atherosclerosis,
including 16.6% (247/1492) of men and 16.7% (62/371)
of women. Among Chinese individuals without MetS,
9.5% (289/3045) of the individuals had carotid athero-
sclerosis. MetS remained significantly associated with ca-
rotid atherosclerosis (OR 1.90, 95% CI 1.58–2.25, P <
0.001). Therefore, MetS is a significant risk factor for ca-
rotid atherosclerosis.
The clinical and biochemical characteristics of the
participants with and without carotid atherosclerosis
among Chinese individuals with MetS
Among Chinese individuals with MetS, the clinical and
biochemical characteristics including the metabolic com-
ponents and the lipid profiles of both men and women
with and without carotid atherosclerosis are shown in
Table 1. The characteristics are stratified by the presence
of carotid atherosclerosis. The mean apoB/apoAΙ ratios
were significantly higher among the participants with ca-
rotid atherosclerosis (0.91 ± 0.02 in men and 0.85 ± 0.03
in women) compared to participants without carotid
atherosclerosis (0.85 ± 0.01 in men and 0.75 ± 0.01 in
women) (P < 0.05). Additionally, there were significant
differences in the TC, LDL-C, FINS, SBP, DBP, UA and
Table 1 Clinical and biochemical characteristics in cluding metabolic components and lipid measures in participant
with and without the carotid atherosclerosis in both genders
Variables Men Women
Carotid atherosclerosis
(−); n = 1245
Carotid atherosclerosis
(+); n = 247
P-value Carotid atherosclerosis
(−); n = 309
Carotid atherosclerosis
(+); n = 62
P-value
Age (ys) 45.14 ± 0.23 53.95 ± 0.58 <0.001 49.61 ± 0.50 58.47 ± 1.17 <0.001
SBP (mm Hg) 137.83 ± 0.31 142.69 ± 1.01 <0.001 137.28 ± 0.61 142.52 ± 1.55 <0.001
DBP (mm Hg) 80.10 ± 0.27 90.16 ± 0.73 <0.001 86.40 ± 0.53 88.53 ± 1.39 <0.001
BMI (kg/m2) 25.75 ± 0.08 25.63 ± 0.17 0.544 24.26 ± 0.17 25.23 ± 0.39 0.021
FPG (mmol/L) 5.70 ± 0.03 5.96 ± 0.10 0.016 5.62 ± 0.06 5.65 ± 0.09 0.848
FINS (pmol/L) 70.01 ± 1.10 60.49 ± 2.21 <0.001 62.99 ± 1.75 72.06 ± 4.63 0.041
HOMA-IR 2.58 ± 0.05 2.34 ± 0.11 0.034 2.28 ± 0.07 2.62 ± 0.18 0.056
TC (mmol/L) 5.28 ± 0.03 5.46 ± 0.06 0.007 5.38 ± 0.05 5.74 ± 0.12 0.005
HDL-C (mmol/L) 1.36 ± 0.01 1.38 ± 0.02 0.284 1.64 ± 0.02 1.53 ± 0.04 0.01
non-HDL-C/HDL-C 2.97 ± 0.02 3.06 ± 0.06 0.149 2.37 ± 0.04 2.82 ± 0.08 <0.001
LDL-C (mmol/L) 3.44 ± 0.02 3.55 ± 0.05 0.041 3.29 ± 0.04 3.65 ± 0.09 0.001
TG (mmol/L) 2.31 ± 0.04 2.13 ± 0.08 0.054 1.72 ± 0.04 2.14 ± 0.13 <0.001
ApoAΙ (g/L) 1.38 ± 0.01 1.40 ± 0.01 0.321 1.54 ± 0.01 1.51 ± 0.02 0.26
ApoB (g/L) 1.17 ± 0.01 1.25 ± 0.02 <0.001 1.13 ± 0.02 1.27 ± 0.04 0.001
ApoB/apoAΙ 0.85 ± 0.01 0.91 ± 0.02 0.001 0.75 ± 0.01 0.85 ± 0.03 0.001
CRP (mg/L) 5.35 ± 0.12 5.67 ± 0.48 0.363 5.34 ± 0.21 4.57 ± 0.35 0.117
HCY (μmol/L) 11.16 ± 0.15 11.6 ± 0.29 0.186 8.28 ± 0.18 9.76 ± 0.38 0.001
GGT (U/L) 61.54 ± 1.60 54.47 ± 3.72 0.074 23.69 ± 1.13 30.95 ± 3.86 0.075
UA (μmol/L) 371.29 ± 2.15 360.94 ± 4.51 0.048 257.46 ± 3.07 283.81 ± 7.56 0.001
Current smoker(%) 41.5 39.7 >0.05 0.6 0 >0.05
SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; FPG: fasting plasma glucose; FINS: fasting insulin; HOMA-IR: homeostasis model
assessment of insulin resistance; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; non-HDL-C: non-high density
lipoprotein cholesterol; TG: triglycerides; ApoAΙ: apolipoprotein AΙ; ApoB: apolipoprotein B; CRP: C-reactive protein; HCY: Homocysteine; GGT: gamma-glutamyl transpeptidase;
UA: uric acid; Carotid atherosclerosis(+): CIMT was≥ 0.9 mm; Carotid atherosclerosis(−): CIMT was < 0.9 mm.
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were also significant differences in the HOMA-IR and
FPG levels among men, and the TG and the non-HDL-
C/HDL-C ratio levels among women. The men (53.95 ±
0.58 ys) developed carotid atherosclerosis at a younger
age than the women (58.47 ± 1.17 ys), among Chinese
individuals with MetS (P < 0.001).Relationship between carotid atherosclerosis and blood
lipid profile and ratios
Spearman correlations between carotid atherosclerosis
and the apoB/apoAΙ ratio and the non-HDL-C/HDL-C
ratio are shown in Table 2. Both the apoB/apoAΙ ratio
and the non-HDL-C/HDL-C ratio positively correlated
with carotid atherosclerosis. The Spearman correlation
coefficients between carotid atherosclerosis and the
apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio
were higher in women compared to men. Binary logistic
regression analysis with forward selection method was
used to assess the OR for CIMT, as shown in Table 3.
Among men, the apoB/apoAΙ ratio was more prominentthan age, SBP, and TG. Among women, the non-HDL-
C/HDL-C ratio was more prominent than age.
The risk of carotid atherosclerosis based on the apoB/
apoAΙ ratio and the non-HDL-C/HDL-C ratio quartiles in
each sex among Chinese individuals with MetS
Following an adjustment for age, BMI, SBP, DBP, TC,
TG, HDL-C, LDL-C, apoB, apoAΙ, INS, IR, CRP, HCY,
GGT, and UA, the ORs of the two ratios increased sig-
nificantly in both men and women, as shown in Table 4.
As compared with quartile 1 (reference), quartile 2 (OR
= 1.205), quartile 3 (OR = 1.541) and quartile 4 (OR =
2.465) of the apoB/apoAΙ ratio in men and quartile 2
(OR = 1.587), quartile 3 (OR = 2.034) and quartile 4 (OR
= 2.772) of the apoB/apoAΙ ratio in women were signifi-
cantly associated with carotid atherosclerosis. Similar re-
lationships were observed for the non-HDL-C/HDL-C
ratio, with the same adjusted, ORs for the increasing
quartiles of the non-HDL-C/HDL-C ratio of quartile 1
(reference), 1.287, 1.627 and 1.843 in men, and quartile
1 (reference), 1.383, 3.200 and 5.847 in women. The ORs
were significantly greater in the highest apoB/apoAΙ
Table 2 Spearman correlations between carotid








ApoB/apoAΙ 0.079 0.002 0.181 <0.001
Non-HDL-C/HDL-C 0.067 0.01 0.2 <0.001
HDL-C (mmol/L) 0.017 0.508 −0.151 0.004
LDL-C (mmol/L) 0.052 0.044 0.181 <0.001
TC (mmol/L) 0.07 0.007 0.141 0.006
ApoB (g/L) 0.103 <0.001 0.162 0.002
ApoAΙ (g/L) 0.018 0.485 −0.06 0.25
HOMA-IR −0.082 0.002 0.102 0.05
CRP (mg/L) −0.017 0.514 −0.069 0.187
Current smoker −0.014 0.59 −0.033 0.527
HDL-C: high density lipoprotein cholesterol; non-HDL-C: non-high density
lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; TC: total
cholesterol; ApoB: apolipoprotein B; ApoAΙ: apolipoprotein AΙ; HOMA-IR:
homeostasis model assessment of insulin resistance; CRP: C-reactive protein.
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quartile, as well as the non-HDL-C/HDL-C ratio, in both
men and women (P < 0.05). Meanwhile, CIMT increased
progressively across the quartiles of the non-HDL-C/
HDL-C ratio (P for trend, < 0.05). The increase in ORs
was more prominent among women than among men.
The diagnostic values of different lipid ratios in detecting
carotid atherosclerosis among Chinese individuals with MetS
To compare the predictive values of the different ratios
in predicting carotid atherosclerosis, we analysed the
ROC curves of the two ratios (apoB/apoAΙ and non-
HDL-C/HDL-C). ROC analysis indicated that the AUC
of the apoB/apoAΙ ratio (0.561) was higher than that of
the non-HDL-C/HDL-C ratio (0.522) in men (P < 0.05)Table 3 Odds ratio and 95% confidence interval of
carotid atherosclerosis associated with blood lipid profile
or ratio in both genders
Variables OR 95% CI P-value
men
apoB/apoAΙ 6.142 3.219-11.720 <0.001
Age (ys) 1.129 1.107-1.151 <0.001
SBP (mm Hg) 1.014 1.003-1.026 0.015
TG (mmol/L) 0.671 0.475-0.949 0.024
women
non-HDL-C/HDL-C 2.054 1.338-3.153 0.001
Age (ys) 1.112 1.072-1.153 <0.001
ApoB: apolipoprotein B; ApoAΙ: apolipoprotein AΙ; SBP: systolic blood pressure;
TG: triglyceride; HDL-C: high density lipoprotein cholesterol; non-HDL-C: non-high
density lipoprotein cholesterol.and the AUC of the apoB/apoAΙ ratio (0.640) was lower
than that of the non-HDL-C/HDL-C ratio (0.695) in
women (P < 0.05). Graphical comparisons of the ROC
curves of these ratios relative to carotid atherosclerosis
are presented in Figure 1. Figures A and B depicted the
discriminatory value of these two ratios relative to ca-
rotid atherosclerosis in men and women, respectively.
There was no significant difference between the apoB/
apoAΙ ratio and the non-HDL-C/HDL-C ratio regarding
the AUC with the Z-statistic (P > 0.05). The AUC of the
apoB/apoAΙ ratio was not larger in women than in men
(P > 0.05), whereas the AUC of the non-HDL-C/HDL-C
ratio was larger in women than men (P < 0.05). The
AUCs for the other parameters were as follows: TG
(AUC = 0.457 in men, AUC = 0.637 in women), non-
HDL-C (AUC = 0.552 in men, AUC = 0.654 in women),
HDL-C (AUC = 0.513 in men, AUC = 0.383 in women),
TC (AUC = 0.555 in men, AUC = 0.609 in women), LDL-
C (AUC = 0.540 in men, AUC = 0.640 in women), IR
(AUC = 0.436 in men, AUC = 0.579 in women), CRP
(AUC = 0.487 in men, AUC = 0.447 in women), apoB
(AUC = 0.580 in men, AUC = 0.626 in women), and
apoAΙ (AUC = 0.514 in men, AUC = 0.454 in women).
Discussion
Previous studies have shown that patients with MetS are
at increased risk of developing vascular diseases, includ-
ing endothelial dysfunction [3,4,25,26]. The Botnia Study
demonstrated that the risk of both coronary heart dis-
ease and stroke increased three-fold among subjects
with metabolic syndrome [4]. In a retrospective analysis
of 5822 men and women, we observed that the risk of
carotid atherosclerosis in a Chinese population with
MetS was approximately twice that of individuals with-
out MetS (P < 0.001).
In the present study, men were found to be at a higher
risk for carotid atherosclerosis compared with women.
Among patients with carotid atherosclerosis, men were
found to be younger than women, which may be the re-
sult of a lower level of apoB, as apoB protects against
the development of atherosclerosis, and is a good pre-
dictor of CVD [13,27-29]. The anti-atherosclerotic ac-
tion of oestrogen may also play a role in this process
[30]. Based on these results, we believe that men with
Mets should be screened for CIMT at a much younger
age compared with women.
Several studies have demonstrated that the apoB/
apoAΙ ratio and the non-HDL-C/HDL-C ratio may be
used to predict the risk of carotid atherosclerosis
[12-14]. Chiadi E Ndumele reported that there were no
significant differences between the ability of the apoB/
apoAΙ ratio and the ability of the non-HDL-C/HDL-C
ratio to predict coronary heart disease in the setting of
MetS [31]. However, none of these previous studies
Table 4 The risk of carotid atherosclerosis according to quartiles of apoB/apoAΙ ratio and non-HDL-C/HDL-C ratio in
both genders
Ratio levels* P for trend
Q1 Q2 Q3 Q4
Men
range of apoB/apoAΙ <0.690 0.690-0.841 0.841-1.000 >1.000
ORs for carotid atherosclerosis 1 1.205(0.768-1.890) 1.541(1.003-2.336) 2.465(1.598-3.803) <0.001
range of non-HDL-C/HDL-C <2.390 2.390-2.937 2.937-3.508 >3.508
ORs for carotid atherosclerosis 1 1.287(0.834–1.987) 1.627(1.060-2.499) 1.843(1.189-2.856) 0.177
Women
range of apoB/apoAΙ <0.594 0.594-0.764 0.764-0.888 >0.888
ORs for carotid atherosclerosis 1 1.587(0.573-4.392) 2.034(0.758-5.496) 2.772(1.051-7.315) <0.001
range of non-HDL-C/HDL-C <1.885 1.885-2.393 2.393-2.955 >2.955
ORs for carotid atherosclerosis 1 1.383(0.424–4.511) 3.200(1.077-9.511) 5.847(1.982-17.245) 0.001
*Covariates for adjustment including age, BMI, SBP, DBP, TC, TG, HDL-C, LDL-C, apoB, apoAΙ, INS, IR, CRP, HCY, GGT, and UA. ApoB: apolipoprotein B; ApoAΙ:
apolipoprotein AΙ; HDL-C: high density lipoprotein cholesterol; non-HDL-C: non-high density lipoprotein cholesterol.
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HDL-C/HDL-C relative to carotid atherosclerosis among
Chinese individuals with MetS. Therefore, in addition to
the correlation between these two ratios and carotid ath-
erosclerosis among Chinese individuals with MetS, we
compared their discriminatory values relative to carotid
atherosclerosis among Chinese individuals with MetS. We
noted that the ratios of apoB/apoAΙ and non-HDL-C/
HDL-C each positively correlated with carotid atheroscler-
osis among Chinese individuals with MetS, particularly
women. The results of the ROC analysis indicated that
there were no significant differences in the abilities of
the ratios of apoB/apoAΙ and non-HDL-C/HDL-C to
predict carotid atherosclerosis among Chinese individ-
uals with MetS.Figure 1 Discriminatory power of apoB/apoAΙ and non-HDL-C/HDL-C
(ROC) curves in men (A) and women (B) ApoB: apolipoprotein B; ApoAΙ:
non-HDL-C: non-high density lipoprotein cholesterol.The AUC of the non-HDL-C/HDL-C ratio was signifi-
cantly lower among men than among women, suggesting
that women were more sensitive and relatively more sus-
ceptible to the burden of this ratio compared with men.
This phenomenon was also observed in both white and
black individuals [32]. The exact reason for this result
must be determined in future studies. This phenomenon
may result from changes in the levels of both HDL-C
and TG, which have been found to exert stronger effects
among women [33].
This study had several limitations. The number of
women subjects was small; therefore, the observed ef-
fects may not be applicable to the general population.
As this was a retrospective study, medication histories
(except lipid-lowering agents), histories of previousfor carotid atherosclerosis by Receiver Operating Characteristic
xapolipoprotein AΙ; HDL-C: high density lipoprotein cholesterol;
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possible intolerance to medications may have been add-
itional limiting factors in the extrapolation of the present
findings to the general population. Given the cross-
sectional nature of our study, the impact of these two
ratios and their interaction with MetS components on
cardiovascular outcomes could not be ascertained.
Hence, we hope to learn the impacts of the comparisons
and the diagnostic values of the investigated ratios in de-
tecting cardiovascular events or diabetes in a future
study. Despite these limitations, the non-HDL-C/HDL-C
ratio and the apoB/apoAΙ ratio may each be useful in
predicting cardiovascular events.
Conclusion
Our findings indicate that Chinese men with MetS de-
velop carotid atherosclerosis at a much younger age than
women with MetS. There were no significant differences
in the ability to predict the risk of carotid atherosclerosis
between the apoB/apoAΙ ratio and the non-HDL-C/HDL-
C ratio among Chinese individuals with MetS. Among
Chinese individuals with MetS, the utility of the non-
HDL-C/HDL-C ratio was found to be greater among
women than among men.
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